Clinical Trials List
2018-11-15 - 2025-06-30
Phase II
Terminated5
-
Trial Applicant
T-TOP Clinical Research Co., Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Shen Ko Division of Hematology & Oncology
- Yao-Chung Liu Division of Hematology & Oncology
- Ting-An Lin Division of Hematology & Oncology
- Chia-Jen Liu Division of Hematology & Oncology
- 林可瀚 Division of Nuclear Medicine
- Chun-Yu Liu Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林立凡 Division of Radiology
- 黃子權 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Ching-Chan Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
30 participants
